Latest Breaking News On - Supervisory board of the company on - Page 1 : comparemela.com

SÜSS MicroTec : Remuneration Report 2023 (incl audit certificate)

2023REMUNERATION REPORT SUSS MICROTEC Remuneration Report 2023 Remuneration Report .

France generalOliver albrechtCornelia ballwiesserThomas roheBurkhardt frickBernd schulteSupervisory board or personnel committeeMicrotec groupPersonnel committeeCompany management boardGerman stock corporation act aktSupervisory board of the companyGerman stock corporation law aktGerman stock corporation lawSupervisory board of the company onSupervisory board

Innate Pharma SA: Innate Pharma Reports First Half 2023 Financial Results and Business Update

Innate Pharma SA: Innate Pharma Reports First Half 2023 Financial Results and Business Update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesJoyson karakunnelHenry wheelerEnregistrement universelInstitut paoli calmettesSonia quaratinoMondher mahjoubiEuropean unionAmerican association for cancer researchUniversity of southamptonAmerican society for clinical oncologyEuropean hematology associationBoard of the company onExchange commissionSupervisory board of the company on

Innate Pharma Reports First Half 2023 Financial Results and Business Update

Innate Pharma Reports First Half 2023 Financial Results and Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesJoyson karakunnelInstitut paoli calmettesSonia quaratinoEnregistrement universelMondher mahjoubiHenry wheelerUniversity of southamptonFrench financial markets authorityInternational conference on malignant lymphomaExchange commissionAmerican society for clinical oncologyBoard of the company onEuropean unionEuropean hematology association

Innate Pharma SA: Innate Pharma Reports First Half 2022 Financial Results and Business Update

Monalizumab and IPH5201 developed in collaboration with AstraZeneca advanced into Phase 3 and 2 clinical trials in lung cancer, triggering $55M in milestone payments Second preclinical asset

United statesPatrick langloisEnregistrement universelMondher mahjoubiBristol myers squibbSally bennettHenry wheelerInstitut paoli calmettesNovo nordiskSupervisory board of the company onCompany orega biotechTreatment of cancer cutaneous lymphoma tumours groupAudit committeeCompany annual report on formCompany onEuropean union

Innate Pharma Reports Full Year 2021 Financial Results and Business Update

Press release content from Business Wire. The AP news staff was not involved in its creation.

United kingdomUnited statesMidi pyréesTracy rossinFrederique bruneMondher mahjoubiBristol myers squibbOlivier martinezFrederic lombardHenry wheelerInstitut paoli calmettesMarcus schindlerJen butlerNovo nordiskSupervisory board of the company onFrench financial markets authority autorit